Skip to main content
. 2025 Oct 23;47(11):878. doi: 10.3390/cimb47110878
AE Adverse event
ATF4 Activating transcription factor 4
CDC Complement-dependent cytotoxicity
cGAS-STING Cyclic GMP-AMP synthase–stimulator of interferon genes
CLEC10A C-type lectin domain-containing 10A
CRC Colorectal cancer
CTL Cytotoxic T lymphocyte
DAMPs Damage-associated molecular patterns
DC Dendritic cell
EGFR Epidermal growth factor receptor
EIF2S1 Eukaryotic translation initiation factor 2 subunit alpha
GM-CSF Granulocyte–macrophage colony-stimulating factor
GZMK Granzyme K
HCC Hepatocellular carcinoma
HSV Herpes simplex virus
HVR Hexon hypervariable region
ICI Immune checkpoint inhibitor
IFNγ Interferon-γ
IL-12 Interleukin-12
IRF3 Interferon regulatory factor 3
MDSC Myeloid-derived suppressor cell
MHC-I Major histocompatibility complex class I
MPA Metastatic pancreatic cancer
NAb Neutralizing antibody
NK cells Natural killer cells
NMIBC Non-muscle-invasive bladder cancer
ORR Objective response rate
OV Oncolytic virus
PDAC Pancreatic ductal adenocarcinoma
S100A1 S100 calcium-binding protein A1
STING Stimulator of interferon gene
TAM Tumor-associated macrophage
TAP Transporter-associated peptide
TBK1 TANK-binding kinase 1
TIME Tumor immune microenvironment
Treg cell Regulatory T cell
TME Tumor microenvironment